As of 10:09:03 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-4,132.7490
-1,376.3510
-215.3950
-5,274.9490
Investing Cash Flow
343,049.9300
342,916.9300
--
-109.7270
Financing Cash Flow
-334,881.6020
-341,660.9300
--
12,500.0000
End Cash Position
6,642.1980
8.8350
129.1860
7,119.1620
Capital Expenditure
--
--
-479.0420
-109.7270
Issuance of Debt
-1,326.5000
1,323.5000
--
12,500.0000
Repurchase of Capital Stock
--
-342,984.4300
--
--
Free Cash Flow
-3,999.7490
-1,376.3510
-215.3950
-5,384.6760
12/31/2021 - 1/5/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NKGN NKGen Biotech, Inc.
0.6741
+2.88%
CERO CERo Therapeutics Holdings, Inc.
0.0649
+8.17%
BDRX Biodexa Pharmaceuticals Plc
4.0700
+0.49%
ALLR Allarity Therapeutics, Inc.
1.1100
-5.13%
CDIO Cardio Diagnostics Holdings, Inc.
0.8700
-5.13%
VRAX Virax Biolabs Group Limited
2.2230
-1.21%
QNRX Quoin Pharmaceuticals, Ltd.
0.6890
+5.89%
GRI GRI Bio, Inc.
0.8400
+1.40%
ENSC Ensysce Biosciences, Inc.
8.10
-0.49%
SPRC SciSparc Ltd.
0.3918
+8.83%